A Digital Life Story to Support Person-centred Care for Older Adults With Dementia Perspectives
Launched by BLEKINGE INSTITUTE OF TECHNOLOGY · Mar 22, 2024
Trial Information
Current as of October 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new digital tool called "Min Memoria," which helps healthcare professionals provide personalized care for older adults with dementia. The idea is to use a "life story" that captures important details about a person's life, memories, and experiences. This life story can help caregivers understand the individual better, create a sense of security, and improve communication. The trial aims to see if this digital application can effectively replace traditional written methods of recording life stories and make it easier for healthcare workers to access and use this information during daily care.
To participate in the trial, you need to be a healthcare professional who currently uses a life story in your care practices. The study will involve focus group discussions and practical testing of the application to gather feedback on its effectiveness. If you join, you can expect to help shape a tool that could greatly improve the quality of care for older adults with dementia, making their experiences more meaningful and personal.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthcare professionals using a life story in daily care.
- Exclusion Criteria:
- • N/A
About Blekinge Institute Of Technology
The Blekinge Institute of Technology (BTH) is a leading academic institution in Sweden, renowned for its innovative approach to research and education in technology and health sciences. With a strong emphasis on interdisciplinary collaboration, BTH is committed to advancing knowledge and improving healthcare outcomes through rigorous clinical trials. The institute leverages cutting-edge technology and methodologies to facilitate research that addresses real-world health challenges, fostering partnerships with industry and healthcare providers to translate findings into practical applications. Through its dedication to excellence in research and education, BTH plays a pivotal role in shaping the future of healthcare and technology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karlskrona, Blekinge, Sweden
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported